Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841359 · ClinicalTrials.gov registry record · Phase 4
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
A Phase 4 study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT01841359 is a Phase 4 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 22 participants.
The verdict
NCT01841359, a Phase 4 study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pramlintide (Symlin) will help to reduce the frequency and severity of hypoglycemia in individuals who have had gastric bypass surgery.
Interventions
- DRUG Pramlintide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-02-02 |
| Est. Completion | 2022-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01841359
The ClinicalTrials.gov registry entry for NCT01841359 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pramlintide is the first listed.
NCT01841359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01841359 about?
NCT01841359 is a clinical study titled "Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery". The purpose of this study is to determine whether pramlintide (Symlin) will help to reduce the frequency and severity of hypoglycemia in individuals who have had gastric bypass surgery.
What is the current status of trial NCT01841359?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2010-02-02. Estimated completion is 2022-02-08.
What interventions are being tested in trial NCT01841359?
The interventions under investigation include: Pramlintide (DRUG).
Who is sponsoring clinical trial NCT01841359?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.